Skip to main content
All lobbying filings

FAEGRE DRINKER BIDDLE & REATH LLP

FAEGRE DRINKER BIDDLE & REATH LLP filed a Q4 report for ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) on January 20, 2026, reporting $80,000 in lobbying income.

Lobbying for ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Coalition to ensure patient access to safe and legitimate online pharmacies

All filings by FAEGRE DRINKER BIDDLE & REATH LLP · Everything ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) has reported

 Filing · LD-2 quarterly report Q4 report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 20, 2026
Income
$80,000
What the client paid this registrant for the period.
Client based in
District of Columbia

Official filing document

 Lobbyists on this filing 2
  • ELLIOT VICE
    Previously held: Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009 - 2010
  • MAYA BOLTER New on this filing
    Previously held: Legislative Intern, Representative Dean Phillips (D-MN-03), September 2019-December 2019

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 4

Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).

Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).

Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).

Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).

 Bills named in this filing 1
  • S. 652
    Protecting Patients from Deceptive Drug Ads Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem